Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 12:55 AM
NCT ID:
NCT00659867
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent must be available before any trial-related procedures
* Male and female patients aged 18 years and older
* Clinically and histologically verified UC
* Duration or Colitis ulcerosa \>8 years (date of first diagnosis)
* Colitis Activity Index ≤ 8
* Activity index of Truelove and Witts: mild
* Ability of subject to understand character and individual consequences of clinical trial
* For women with childbearing potential, adequate contraception.
Exclusion Criteria:
* Known intraepithelial neoplasia or colorectal cancer
* Coagulopathy (Prothrombin time \<50% of control, Partial thromboplastin time \>50 s)
* Impaired renal function (Creatinine \>1.2 mg/dL)
* Pregnancy or breast feeding
* Inability to obtain informed consent
* Active GI Bleeding
* Known allergy to methylene blue or fluorescein
* Participation in other clinical trials within the last 4 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00659867
Study Brief:
Protocol Section:
NCT00659867